Skip to main content

Fiscal Wizard · Single-issue tearsheet

CBIO / Jun 21, 2026 Run #7466

CBIO

Crescent Biopharma, Inc.

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.

Composite verdict

C 56.8 / 100
Bullish setup · Reversal 4 drivers · 2 gates blocking
  • Declining Volume
  • Wedge Pattern
  • Rate of Change
Consider long call target Δ ~0.50 · ~35 DTE Bullish setup, Grade C → ITM call target

Industry rank 58th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 16 signals0% Bear
Momentum Bullish 76Mean-reversion Bullish 60

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

18.3 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Gross Margin 75
Free Cash Flow Yield 0
P/B 75
EPS Growth (YoY) 0
Days Sales Outstanding 0

Technicals Bullish

95.3 / 100

Bullish setup leads (Declining Volume, Rate of Change, Wedge Pattern); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Declining Volume 81
Rate of Change 76
Wedge Pattern 75

Risk Gates

2 blocking 5 caution

2 guards active, 25 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CBIO.